Materials and methods for treatment of retinal diseases

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/85 (2006.01) A61K 31/70 (2006.01) A61K 48/00 (2006.01) C12N 9/00 (2006.01) C12N 15/11 (2006.01) C12N 15/86 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2287495

The subject invention provides materials and methods for efficient, specific expression of proteins in retinal photoreceptor cells. Specifically, the constructs are composed of an adeno-associated vital vector containing a rod or cone-opsin promoter. These materials and methods can be used in therapies for retinal diseases. In one embodiment, ribozymes which degrade mutant mRNA are used to treat retinitis pigmentosa.

La présente invention concerne des produits et des traitements suscitant une expression satisfaisante et spécifique de protéines dans les cellules photorécepteurs de la rétine. Plus particulièrement, les produits de recombinaison sont constitués d'un vecteur viral associé aux adénovirus renfermant un promoteur d'opsine des bâtonnets ou des cônes rétiniens. Ces produits et traitement conviennent à des thérapies adaptées à des affections rétiniennes. Selon une réalisation, pour soigner la rétinite pigmentaire, on utilise des ribozymes qui dégradent l'ARNm mutant.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Materials and methods for treatment of retinal diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Materials and methods for treatment of retinal diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Materials and methods for treatment of retinal diseases will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1511927

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.